Back to home pageProfessional Education

A list of recently completed PGY1 residency research projects is below:

  • The impact of switching from trough-guided to AUC guided vancomycin dosing on hospital resources
  • Evaluation of the efficacy and safety of warfarin vs. DOACs after bioprosthetic valve replacement
  • Comparison of argatroban vs. heparin for VV-ECMO anticoagulation and the impact on patient outcomes and safety
  • De-escalation of empiric vancomycin for pneumonia driven by pharmacist ordering of MRSA nasal screen
  • Impact of MRSA PCR assay and MRSA nasal culture on de-escalation of empiric vancomycin therapy for pneumonia
  • Risk factors for high-dose methotrexate-induced nephrotoxicity in the treatment of hematologic malignancies
  • Evaluation of cephalexin for treatment of acute uncomplicated cystitis in patients discharged home from the emergency department
  • Evaluating the Effectiveness of Oral Antibiotics for Definitive Treatment of Enterobacteriaceae Associated Bloodstream Infections
  • Characterizing medical residents’ opioid prescribing patterns before and after the implementation of new opioid laws
  • Assessing Oral Anticoagulation after an Acute Ischemic Stroke
  • Evaluating Antipsychotic Use for ICU Delirium in an Academic Medical Center
  • Assessing Adherence to the Medication Components of the Severe Sepsis 3 and 6 – hour Resuscitation Bundle for the Treatment of Sepsis, Severe Sepsis, and Septic Shock
  • Comparing Catheter-Directed Alteplase vs. Systemic Alteplase 100mg v. Systemic Alteplase 50mg Associated Bleeds
  • Apixaban Major Bleeding in Atrial Fibrillation:  Patient Characteristics, Management and Outcomes
  • Clinical and Economic Outcomes of Warfarin Versus Direct Oral Anticoagulants (DOACs) Following Alteplase for the Treatment of Pulmonary Embolism (PE)
  • Hemodynamic Effects of Dexmedetomidine Compared to Propofol in Critically Ill Adults
  • Evaluation of De-Escalation of Empirically Initiated Broad-Spectrum Antibiotics in Patients Diagnosed with Healthcare-Associated Pneumonia
  • Evaluation of Compliance to an Intravenous Insulin Infusion Protocol in the Management of Diabetic Ketoacidosis
  • Evaluation of Specialty Pharmacy Services and Treatment Outcomes for Hepatitis C at a Large Academic Medical Center
  • An Economic Evaluation Comparing Three Different Regimens (Moxifloxacin vs. Levofloxacin vs. Ceftriaxone/Azithromycin) for the Treatment of Community Acquired Pneumonia
  • Development, Optimization and Implementation of Trigger Tool Methodology to Improve Identification of Adverse Medication Events
  • Major Bleeding with Oral Anticoagulants
  • Pharmacist Dosed Patient Controlled Analgesia in a Tertiary Academic Center
  • Pilot Expansion for a Therapeutic Drug Monitoring (TDM) Service
  • Evaluation of Effectiveness and Parent Satisfaction after the Implementation of Intranasal Fentanyl as an Adjunctive Agent in Pediatric Procedural Pain Control
  • Evaluation of Diabetic Ketoacidosis Management at Beaumont, Royal Oak
  • Evaluation of Vancomycin Powder Application During Spine Surgery
  • Impact of Three Antifibrinolytic Regimens in Cardiac Surgery
  • The QTc prolonging effect of combining haloperidol with drugs at risk for QTc prolongation
  • Clinical and Economic Outcomes Associated with Propofol Administration in Patients with Reduced vs. Normal Ejection Fractions
  • Evaluation of the safety and appropriateness of an insulin infusion targeting 180-200 mg/dL in a medical intensive care unit
  • Evaluating the association between vancomycin and AUC on the incidence of AKI in neonatal ICU patients
  • An assessment of the role of alternative anticoagulants for management of Heparin induced thrombocytopenia
  • Capturing the impact of student pharmacist’s involvement in a collaborative practice model
  • Evaluation of U-500 insulin dose requirements in patients admitted to the hospital
  • Assessment of compliance in an outpatient clinic to ACC/AHA recommendations in atrial fibrillation and atrial flutter patients
  • Evaluation of the use and impact of an antibiotic time-out tool
  • Evaluation of inappropriate medication formulation usage in patients with enteral tubes
  • Influence of induction immunosuppression selection on one-year patient outcomes in renal transplant recipients
  • Evaluation of Physician v. Pharmacist-led patient controlled analgesia (PCA) dosing
  • Evaluation of compliance to USP 800 at a private, not-for-profit teaching hospital
  • Efficacy of vancomycin for treatment of coagulase negative staphylococcus bacteremia – does MIC matter?
  • Major Bleeding with apixaban in atrial fibrillation: patient characteristics, management & outcomes
  • Evaluation of the risk of major bleeding in patients receiving triple antithrombotic therapy with dual antiplatelet therapy and oral anticoagulation 

Copyright © Beaumont Health. All Rights Reserved.
Beaumont Health
2021
Beaumont Logo
logo
Beaumont Health is Michigan's largest health care system providing compassionate, extraordinary care to patient and families. Your partner in education and development.